Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
Targeting the glycolytic PFKFB3 enzyme is being studied as a therapeutic strategy against cancer. Here the authors identify PFKFB3 as being involved in homologous recombination (HR) repair of DNA double strand breaks (DSBs) and present a PFKFB3 inhibitor.
Guardado en:
Autores principales: | Nina M. S. Gustafsson, Katarina Färnegårdh, Nadilly Bonagas, Anna Huguet Ninou, Petra Groth, Elisee Wiita, Mattias Jönsson, Kenth Hallberg, Jemina Lehto, Rosa Pennisi, Jessica Martinsson, Carina Norström, Jessica Hollers, Johan Schultz, Martin Andersson, Natalia Markova, Petra Marttila, Baek Kim, Martin Norin, Thomas Olin, Thomas Helleday |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5be37faa19d4d1fbbb9c428f096c524 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functional diversity of PFKFB3 splice variants in glioblastomas.
por: Ulli Heydasch, et al.
Publicado: (2021) -
Canonical and Non-Canonical Roles of PFKFB3 in Brain Tumors
por: Reinier Alvarez, et al.
Publicado: (2021) -
Targeting PFKFB3 alleviates cerebral ischemia-reperfusion injury in mice
por: Olga Burmistrova, et al.
Publicado: (2019) -
Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming
por: Jia Liu, et al.
Publicado: (2020) -
Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression
por: Alyssa La Belle Flynn, et al.
Publicado: (2019)